In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

Next Generation RNA Therapeutics Summit

May 24, 2022 - 09:00 AM - May 26, 04:00 PM
Hanson Wade
Omni Parker House
60 School Street,

ZIP: 02108
Phone: +16174554188

Ticket Price: USD 2599.00 - USD 5097.00

Built with biopharmaceutical industry insights, this in-person conference will delve into novel and emerging RNA therapeutics and vaccines such as self-amplifying mRNA vaccines, circular RNA therapeutics, and tRNA-based gene therapies to the scene for discovery and translation of novel modalities that offer superior targeted delivery, selectivity, durability, and scalability compared to the current generations.

With 20+ pioneering speakers from large pharma, innovative biotech, and KOLs of academia who are shaping the landscape of next-generation RNA therapeutics for the scientific community worldwide, join us in Boston to hear how they address the major challenges facing the industry.

This conference will:
• Explore the current state of play and future of next generation RNA therapeutics
• Discover next generation RNA therapeutics and vaccine modalities
• Optimize the latest advancements of next generation RNA formulation and delivery strategies
• Tune into how companies are innovating immunotherapy approaches through next generation RNA therapeutics
• Combat toxicology, pharmacology and scalability challenges of next generation RNA therapeutics

Tickets    https://go.evvnt.com/996084-2?pid=1052
Brochure https://go.evvnt.com/996084-3?pid=1052

Drug Developer Pricing - Conference + 2 Workshops - On the Door USD 4197.00
Drug Developer Pricing - Conference + 1 Workshop - On the Door USD 3598.00
Drug Developer Pricing - Conference Only - On the Door USD 2999.00
Industry Pricing - Conference + 2 Workshops - On the Door USD 5097.00
Industry Pricing - Conference + 1 Workshop - On the Door USD 4348.00
Industry Pricing - Conference Only - On the Door USD 3599.00
Research Institutes Pricing - Conference + 2 Workshops - On the Door USD 3697.00
Research Institutes Pricing - Conference + 1 Workshop - On the Door USD 3148.00
Research Institutes Pricing - Conference Only - On the Door USD 2599.00

Category: Conferences | Science, Health & Medicine | Oncology

Speaker Details

Andreas Kuhn Senior Vice President - RNA Biochemistry & Manufacturing BioNTech, John Androsavich Global Head - RNA Medicine Lead Pfizer, Susan Goody Director & Head of Toxicology Moderna Therapeutics, Nathaniel Wang Chief Executive Officer & Co-Founder Replicate Bioscience, Alex Wesselhoeft Founder & Director of Molecular Biology Orna Therapeutics, Tasuku Kitada President, Director, Co-founder, Head of Research & Development Strand Therapeutics Inc., Yusuf Erkul Co-founder & Chief Executive Officer Kernal Biologics Inc., Philip Santangelo Professor Emory University School Of Medicine, Gopi Shanker Chief Scientific Officer Tevard Bioscience, Mathieu Ghadanfar Chief Medical Officer & Research & Development Director Ziphius Vaccines, Mat Falkowski Chief Executive Officer CEO Circularis Biotechnologies Inc., Robert Kruse Clinical Fellow Harvard College, Thomas Colace Assistant Director, LNP Formulation Kernal Biologics Inc., Gillis Otten Head of Immunology Research Seqirus Inc., Allen Horhota Senior Director & Head of Delivery Orna Therapeutics, Anna Blakney Assistant Professor University of British Columbia, Andrew Geall Co-founder & Chief Development Officer Replicate Bioscience, Ethan Settembre Vice President, Head of Research Seqirus Inc., Velia Siciliano Principal Investigator - Synthetic & System Biology for Biomedicine Italian Institute of Technology, Andy Berglund Director - Ribonucleic Acid Institute & Professor - Biological Sciences University at Albany

Event Categories
Keywords: chemistry, Pharmacology , toxicolog


Events Calendar

1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31 1 2 3 4


VIP Life Time Subscription to our Newsletters!